شرکتسرمسازیشهیدقاضیتبریز
دقاضی | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 24,040 1.78
Close Price: 23,520
Balance Sheet
AGM
Interim
2026/07/07 Fiscal Year 2026/03/2012 Month | 2025/05/07 Fiscal Year 2025/03/2012 Month | 2024/05/08 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 901.813 Billion | 1.064 Trillion | 1.033 Trillion | |
Short-Term Investments | 139 Million | 194 Million | 256 Million | |
Trade Receivables | 21.803 Trillion | 12.902 Trillion | 7.461 Trillion | |
Prepayments | 6.25 Trillion | 1.55 Trillion | 2.048 Trillion | |
Raw Materials & Packaging Inventory | 3.432 Trillion | 2.63 Trillion | 1.999 Trillion | |
Work-in-Progress Inventory | 23.901 Billion | 11.118 Billion | 11.193 Billion | |
Finished Goods Inventory | 968.881 Billion | 622.879 Billion | 346.925 Billion | |
Spare Parts Inventory | 1.116 Trillion | 585.833 Billion | 437.032 Billion | |
Goods in Transit | 2.375 Trillion | 223.197 Billion | - | |
Our Goods on Consignment with Others | 619 Million | 15.13 Billion | 23.039 Billion | |
Other Inventories | 47.005 Billion | 60.919 Billion | 40.434 Billion | |
Inventories | 7.963 Trillion | 4.149 Trillion | 2.857 Trillion | |
Total Current Assets | 36.918 Trillion | 19.666 Trillion | 13.398 Trillion | |
Long-Term Investments | 51.689 Billion | 51.689 Billion | 51.719 Billion | |
Long-Term Trade Receivables | 40.314 Billion | 29.865 Billion | 21.265 Billion | |
Intangible Assets | 4.078 Billion | 768 Million | 1.083 Billion | |
Property, Plant & Equipment | 11.365 Trillion | 10.865 Trillion | 3.91 Trillion | |
Net Fixed Assets | 11.365 Trillion | 10.865 Trillion | 3.91 Trillion | |
Total Non-Current Assets | 11.461 Trillion | 10.947 Trillion | 3.984 Trillion | |
Total Assets | 48.379 Trillion | 30.614 Trillion | 17.382 Trillion | |
Trade Payables | 2.321 Trillion | 995.768 Billion | 709.953 Billion | |
Income Tax Provision | 3.594 Trillion | 1.901 Trillion | 1.868 Trillion | |
Proposed & Payable Dividends | 3.868 Trillion | 4.016 Trillion | 3.142 Trillion | |
Current Borrowings | 5.027 Trillion | 687.072 Billion | 3.236 Trillion | |
Total Current Liabilities | 14.81 Trillion | 7.6 Trillion | 8.956 Trillion | |
Long-Term Borrowings | 3.514 Trillion | 3.524 Trillion | - | |
Employee Termination Benefits Provision | 419.678 Billion | 243.625 Billion | 137.19 Billion | |
Total Non-Current Liabilities | 3.933 Trillion | 3.768 Trillion | 137.19 Billion | |
Total Liabilities | 18.744 Trillion | 11.368 Trillion | 9.093 Trillion | |
Capital | 9.89 Trillion | 1.7 Trillion | 1.7 Trillion | |
Capital Raise in Progress | 495.846 Billion | 8.19 Trillion | - | |
Retained Earnings | 18.382 Trillion | 9.275 Trillion | 6.513 Trillion | |
Legal Reserve | 961.584 Billion | 170 Billion | 170 Billion | |
Share Premium Reserve | -93.31 Billion | -89.763 Billion | -93.853 Billion | |
Total Equity | 29.636 Trillion | 19.246 Trillion | 8.289 Trillion | |
Total Liabilities & Equity | 48.379 Trillion | 30.614 Trillion | 17.382 Trillion | |
Approved Capital | 9.89 Trillion | 1.7 Trillion | 1.7 Trillion | |
Approved Capital Raise in Progress | 495.846 Billion | 8.19 Trillion | - | |
Approved Retained Earnings | 8.355 Trillion | 3.341 Trillion | 2.297 Trillion | |
Approved Legal Reserve | 961.584 Billion | 170 Billion | 170 Billion | |
Total Approved Equity (at AGM) | 19.703 Trillion | 13.401 Trillion | 4.167 Trillion |